These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Pathological Stage T3a Significantly Increases Disease Recurrence across All Tumor Sizes in Renal Cell Carcinoma. Chevinsky M, Imnadze M, Sankin A, Winer A, Mano R, Jakubowski C, Mashni J, Sjoberg DD, Chen YB, Tickoo SK, Reuter VE, Hakimi AA, Russo P. J Urol; 2015 Aug; 194(2):310-5. PubMed ID: 25676433 [Abstract] [Full Text] [Related]
5. Reevaluation of TNM staging of renal cortical tumors: recurrence and survival for T1N0M0 and T3aN0M0 tumors are equivalent. Gilbert SM, Murphy AM, Katz AE, Goluboff ET, Sawczuk IS, Olsson CA, Benson MC, McKiernan JM. Urology; 2006 Aug; 68(2):287-91. PubMed ID: 16904438 [Abstract] [Full Text] [Related]
11. Pathological T3a Upstaging of Clinical T1 Renal Cell Carcinoma: Outcomes According to Surgical Technique and Predictors of Upstaging. Jeong SH, Kim JK, Park J, Jeon HJ, Yoon MY, Jeong CW, Ku JH, Kim HH, Kwak C. PLoS One; 2016 Nov; 11(11):e0166183. PubMed ID: 27861519 [Abstract] [Full Text] [Related]
12. Location of extrarenal tumor extension does not impact survival of patients with pT3a renal cell carcinoma. Margulis V, Tamboli P, Matin SF, Meisner M, Swanson DA, Wood CG. J Urol; 2007 Nov; 178(5):1878-82. PubMed ID: 17868733 [Abstract] [Full Text] [Related]
13. The influence of clinical and pathological stage discrepancy on cancer specific survival in patients treated for renal cell carcinoma. Svatek RS, Lotan Y, Herman MP, Duchene DA, Sagalowsky AI, Cadeddu JA. J Urol; 2006 Oct; 176(4 Pt 1):1321-5; discussion 125. PubMed ID: 16952621 [Abstract] [Full Text] [Related]
14. Small renal cell carcinomas: correlation of size with tumor stage, nuclear grade, and histologic subtype. Hsu RM, Chan DY, Siegelman SS. AJR Am J Roentgenol; 2004 Mar; 182(3):551-7. PubMed ID: 14975944 [Abstract] [Full Text] [Related]
15. Results of computerized tomography guided percutaneous ablation of renal masses with nondiagnostic pre-ablation pathological findings. Permpongkosol S, Link RE, Solomon SB, Kavoussi LR. J Urol; 2006 Aug; 176(2):463-7; discussion 467. PubMed ID: 16813865 [Abstract] [Full Text] [Related]
16. Renal cell carcinoma: analysis of postoperative recurrence patterns. Chae EJ, Kim JK, Kim SH, Bae SJ, Cho KS. Radiology; 2005 Jan; 234(1):189-96. PubMed ID: 15537838 [Abstract] [Full Text] [Related]
17. The accuracy of multidetector computerized tomography for evaluating tumor thrombus in patients with renal cell carcinoma. Guzzo TJ, Pierorazio PM, Schaeffer EM, Fishman EK, Allaf ME. J Urol; 2009 Feb; 181(2):486-90; discussion 491. PubMed ID: 19100567 [Abstract] [Full Text] [Related]
18. Does stage T3a renal cell carcinoma embrace a homogeneous group of patients? Gofrit ON, Shapiro A, Pizov G, Landau EH, Katz R, Zorn KC, Pode D. J Urol; 2007 May; 177(5):1682-6. PubMed ID: 17437782 [Abstract] [Full Text] [Related]
19. Reassessment of the 1997 TNM classification system for renal cell carcinoma. Elmore JM, Kadesky KT, Koeneman KS, Sagalowsky AI. Cancer; 2003 Dec 01; 98(11):2329-34. PubMed ID: 14635066 [Abstract] [Full Text] [Related]
20. Are small renal tumors harmless? Analysis of histopathological features according to tumors 4 cm or less in diameter. Remzi M, Ozsoy M, Klingler HC, Susani M, Waldert M, Seitz C, Schmidbauer J, Marberger M. J Urol; 2006 Sep 01; 176(3):896-9. PubMed ID: 16890647 [Abstract] [Full Text] [Related] Page: [Next] [New Search]